Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSIGLITAZONE Cause Congestive cardiomyopathy? 125 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Congestive cardiomyopathy have been filed in association with ROSIGLITAZONE. This represents 0.3% of all adverse event reports for ROSIGLITAZONE.

125
Reports of Congestive cardiomyopathy with ROSIGLITAZONE
0.3%
of all ROSIGLITAZONE reports
31
Deaths
99
Hospitalizations

How Dangerous Is Congestive cardiomyopathy From ROSIGLITAZONE?

Of the 125 reports, 31 (24.8%) resulted in death, 99 (79.2%) required hospitalization.

Is Congestive cardiomyopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSIGLITAZONE. However, 125 reports have been filed with the FAERS database.

What Other Side Effects Does ROSIGLITAZONE Cause?

Myocardial infarction (17,018) Cardiac failure congestive (15,085) Cerebrovascular accident (7,899) Coronary artery disease (4,982) Acute myocardial infarction (2,437) Cardiac disorder (1,732) Coronary arterial stent insertion (1,698) Coronary artery bypass (1,181) Chest pain (990) Myocardial ischaemia (970)

What Other Drugs Cause Congestive cardiomyopathy?

SACUBITRIL\VALSARTAN (218) DOXORUBICIN (204) CYCLOPHOSPHAMIDE (180) CLOZAPINE (120) QUETIAPINE (107) EPIRUBICIN (95) BISOPROLOL (92) FUROSEMIDE (91) RITUXIMAB (90) VINCRISTINE (87)

Which ROSIGLITAZONE Alternatives Have Lower Congestive cardiomyopathy Risk?

ROSIGLITAZONE vs ROSUVASTATIN ROSIGLITAZONE vs ROSUVASTATIN\ROSUVASTATIN ROSIGLITAZONE vs ROTIGOTINE ROSIGLITAZONE vs ROXADUSTAT ROSIGLITAZONE vs ROXICODONE

Related Pages

ROSIGLITAZONE Full Profile All Congestive cardiomyopathy Reports All Drugs Causing Congestive cardiomyopathy ROSIGLITAZONE Demographics